These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


156 related items for PubMed ID: 8746343

  • 1. Lymphoproliferative responses to Borrelia burgdorferi in circumscribed scleroderma.
    Breier P, Klade H, Stanek G, Poitschek C, Kirnbauer R, Dorda W, Aberer E.
    Br J Dermatol; 1996 Feb; 134(2):285-91. PubMed ID: 8746343
    [Abstract] [Full Text] [Related]

  • 2. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
    Buechner SA, Lautenschlager S, Itin P, Bircher A, Erb P.
    Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
    [Abstract] [Full Text] [Related]

  • 3. [Lymphocyte proliferation test in cutaneous manifestations of Lyme borreliosis].
    Breier F, Klade H, Stanek G.
    Wien Med Wochenschr; 1995 Jun; 145(7-8):170-3. PubMed ID: 7610666
    [Abstract] [Full Text] [Related]

  • 4. Borrelia burgdorferi and different types of morphea.
    Aberer E, Klade H, Stanek G, Gebhart W.
    Dermatologica; 1991 Jun; 182(3):145-54. PubMed ID: 1879581
    [Abstract] [Full Text] [Related]

  • 5. Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses.
    Krause A, Burmester GR, Rensing A, Schoerner C, Schaible UE, Simon MM, Herzer P, Kramer MD, Wallich R.
    J Clin Invest; 1992 Sep; 90(3):1077-84. PubMed ID: 1522216
    [Abstract] [Full Text] [Related]

  • 6. Morphoea: a manifestation of infection with Borrelia species?
    Eisendle K, Grabner T, Zelger B.
    Br J Dermatol; 2007 Dec; 157(6):1189-98. PubMed ID: 17941947
    [Abstract] [Full Text] [Related]

  • 7. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
    Lebech AM.
    APMIS Suppl; 2002 Dec; (105):1-40. PubMed ID: 11985118
    [Abstract] [Full Text] [Related]

  • 8. A novel lymphocyte transformation test (LTT-MELISA) for Lyme borreliosis.
    Valentine-Thon E, Ilsemann K, Sandkamp M.
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):27-34. PubMed ID: 16876371
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antibody responses to borrelia IR(6) peptide variants and the C6 peptide in Swedish patients with erythema migrans.
    Tjernberg I, Sillanpää H, Seppälä I, Eliasson I, Forsberg P, Lahdenne P.
    Int J Med Microbiol; 2009 Aug; 299(6):439-46. PubMed ID: 19138558
    [Abstract] [Full Text] [Related]

  • 11. [Skin manifestations of Lyme borreliosis].
    Nammous AH, Zubacki D, Dobrzycki I.
    Przegl Lek; 2006 Aug; 63(4):227-30. PubMed ID: 17080746
    [Abstract] [Full Text] [Related]

  • 12. [The humoral immunological response of patients with Lyme disease].
    Skripnikova IA, Anan'eva LP, Barskova VG, Ushakova MA.
    Ter Arkh; 1995 Aug; 67(11):53-6. PubMed ID: 8571255
    [Abstract] [Full Text] [Related]

  • 13. Detection of Borrelia burgdorferi-specific CD8+ cytotoxic T cells in patients with Lyme arthritis.
    Busch DH, Jassoy C, Brinckmann U, Girschick H, Huppertz HI.
    J Immunol; 1996 Oct 15; 157(8):3534-41. PubMed ID: 8871653
    [Abstract] [Full Text] [Related]

  • 14. Analysis of some peripheral blood lymphocyte subsets in relation to Borrelia burgdorferi antibodies in patients with Lyme disease.
    Zajkowska JM, Hermanowska-Szpakowicz T, Wysocka J, Kondrusik M, Pancewicz SA, Grygorczuk S.
    Rocz Akad Med Bialymst; 2000 Oct 15; 45():184-98. PubMed ID: 11712430
    [Abstract] [Full Text] [Related]

  • 15. [In vivo and in vitro detection of borrelia infection in morphea-like skin changes with negative Borrelia serology].
    Schempp C, Bocklage H, Owsianowski M, Lange R, Orfanos CE, Gollnick H.
    Hautarzt; 1993 Jan 15; 44(1):14-8. PubMed ID: 8436502
    [Abstract] [Full Text] [Related]

  • 16. Evidence for spirochetal origin of circumscribed scleroderma (morphea).
    Aberer E, Stanek G, Ertl M, Neumann R.
    Acta Derm Venereol; 1987 Jan 15; 67(3):225-31. PubMed ID: 2442935
    [Abstract] [Full Text] [Related]

  • 17. The absence of antibodies against Borrelia burgdorferi in the sera of Japanese patients with localized scleroderma.
    Akimoto S, Ishikawa O, Miyachi Y.
    J Rheumatol; 1996 Mar 15; 23(3):573-4. PubMed ID: 8833012
    [No Abstract] [Full Text] [Related]

  • 18. Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection.
    Pohl-Koppe A, Balashov KE, Steere AC, Logigian EL, Hafler DA.
    J Immunol; 1998 Feb 15; 160(4):1804-10. PubMed ID: 9469440
    [Abstract] [Full Text] [Related]

  • 19. [Morphaea profunda].
    Büchner SA, Rufli T.
    Hautarzt; 1990 Mar 15; 41(3):155-7. PubMed ID: 2188936
    [Abstract] [Full Text] [Related]

  • 20. Antibodies to the Borrelia burgdorferi flagellum in patients with scleroderma, granuloma annulare and porphyria cutanea tarda.
    Halkier-Sørensen L, Kragballe K, Hansen K.
    Acta Derm Venereol; 1989 Mar 15; 69(2):116-9. PubMed ID: 2564227
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.